| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/23/2008 | EP1946777A1 Substituted pyrazoline for preventing weight gain |
| 07/23/2008 | EP1946764A1 Nutrient composition |
| 07/23/2008 | EP1946762A1 Scavenger of harmful active oxygen and/or free radical in living body |
| 07/23/2008 | EP1946755A1 Jelly composition |
| 07/23/2008 | EP1945670A2 Therapeutic agent |
| 07/23/2008 | EP1945635A2 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 07/23/2008 | EP1945633A1 Compounds and compositions as ppar modulators |
| 07/23/2008 | EP1945628A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 07/23/2008 | EP1945304A2 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs |
| 07/23/2008 | EP1945238A2 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 07/23/2008 | EP1945235A1 Probiotics to influence fat metabolism and obesity |
| 07/23/2008 | EP1945207A2 Pharmaceutical use of substituted amides |
| 07/23/2008 | EP1945199A1 Leucine rich composition |
| 07/23/2008 | EP1945195A2 Novel use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases |
| 07/23/2008 | EP1945044A2 Compositions and methods for increasing lean muscle mass and/or reducing fat gain |
| 07/23/2008 | EP1945032A2 Improved toleration iron supplement compositions |
| 07/23/2008 | EP1732933B1 Compounds for treating dyslipidemia |
| 07/23/2008 | EP1689249B1 Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP1597247B1 Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof |
| 07/23/2008 | EP1551814B1 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists |
| 07/23/2008 | EP1420774B1 Preparation and diabetic use of gibberellins |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1325745B1 Preventives and remedies for complications of diabetes |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1163271B1 Recombinant il-18 antibodies and their use |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | EP0978284B1 Use of 15-keto-prostaglandin-e compounds as endothelin antagonists |
| 07/23/2008 | EP0831769B2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 07/23/2008 | CN101228162A 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| 07/23/2008 | CN101228157A Amino acid salts of rosiglitazone |
| 07/23/2008 | CN101228144A Activator for peroxisome proliferator-activated receptor |
| 07/23/2008 | CN101228143A Thiazole derivative |
| 07/23/2008 | CN101228128A A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 07/23/2008 | CN101228127A Novel piperidine derivative |
| 07/23/2008 | CN101228123A Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia |
| 07/23/2008 | CN101228108A Compounds for treatment of lipase-mediated diseases |
| 07/23/2008 | CN101227911A Use of spirostenols to treat mitochondrial disorders |
| 07/23/2008 | CN101225425A Process for preparing hypoglycemic active peptide by hydrolysis scabby grape protein |
| 07/23/2008 | CN101225365A Composite bacteria leaven and preparation method thereof |
| 07/23/2008 | CN101225361A Golden fungus fermentation liquor or sesquiterpenes produced by fermentation of golden fungus liquid |
| 07/23/2008 | CN101225042A Yacon diterpene acid compounds, medicine composition, preparation method and use in preparation of medicine treating diabetes mellitus |
| 07/23/2008 | CN101224283A Chinese traditional medicine compounds for treating diabetes and preparing method thereof |
| 07/23/2008 | CN101224280A Lick brick for treating animal nutrient metabolism disease |
| 07/23/2008 | CN101224260A Health product compounds consisting of lecithin, grape seed extract and ginkgo leaf extract |
| 07/23/2008 | CN101224256A Antidiabetics compounds of Chinese and western materia medica and preparing method thereof |
| 07/23/2008 | CN101224253A Chinese traditional medicine compounds for treating diabetic foot and preparing method thereof |
| 07/23/2008 | CN101224246A Preparing method of loquat leaf total triterpenic acid and antidiabetic use thereof |
| 07/23/2008 | CN101224240A Antidiabetics extract, preparing method and uses thereof |
| 07/23/2008 | CN101224233A Cassia plant extract and extracting method thereof |
| 07/23/2008 | CN101224205A Compound of atorvastatin and levorotatory amlodipine and preparing method thereof |
| 07/23/2008 | CN101224202A Weight reducing compound |
| 07/23/2008 | CN101224004A Medicinal granules for the elderly to lose weight and preparing method thereof |
| 07/23/2008 | CN101223996A Producing process of lotus leaf tea for decreasing hematic fat |
| 07/23/2008 | CN101223956A Fast food instant porridge and preparing method thereof |
| 07/23/2008 | CN101223952A Stable rice bran noodle and preparing method thereof |
| 07/23/2008 | CN101223947A High gluten rice of maize |
| 07/23/2008 | CN101223940A Universal liquid feed specially for milk cow and preparing method thereof |
| 07/23/2008 | CN101223937A Edible pet quid containing nutrition rod and preparing method thereof |
| 07/23/2008 | CN101223913A Liquid feed for improving newborn piglet survival ratio and growth performance |
| 07/23/2008 | CN101223897A Special food with bean curd, yam and sticky rice as main materials for diabetes patient and producing method thereof |
| 07/23/2008 | CN101223896A Special food with sweet potato, yam and sticky rice as main materials for diabetes patient and producing method thereof |
| 07/23/2008 | CN100405062C Therapeutic and diagnostic uses of antibody specificity profiles |
| 07/23/2008 | CN100404536C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/23/2008 | CN100404534C Use of berberine derivativein preparing medicament for treating type-2 diabetes, adjusting blood sugar and blood fat |
| 07/23/2008 | CN100404529C 2,4-bis (trifluoroethoxy)pyridine compound and drug containing the compound |
| 07/23/2008 | CN100404074C Implantable pouch seeded with insulin-producing cells to treat diabetes |
| 07/23/2008 | CN100404066C Chinese medicine for treating diabetes mellitus and its preparation |
| 07/23/2008 | CN100404048C Method for preparing blood fat-reducing product |
| 07/23/2008 | CN100404024C Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 07/23/2008 | CN100403917C Method for the fractionation of oil and polar lipid-containing native raw material |
| 07/22/2008 | US7402704 Arylsulfones and uses related thereto |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 07/22/2008 | US7402611 Use of amino acids for making medicines for treating to insulin-resistance |
| 07/22/2008 | US7402597 e.g. [[7-Allyl-3-[2-[2-(2,4-dichlorophenyl)-5-isopropyl-4-oxazolyl]ethyl]-1,2-benzisoxazol-6-yl]oxy]acetic acid; with vehicles (lactose, D-mannitol, glucose), disintegrators (starch or carboxymethylcellulose calcium ), binders (hydroxypropylcellulose) and lubricants (magnesium stearate or talc) |
| 07/22/2008 | US7402590 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402577 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/22/2008 | US7402571 Methods and pharmaceutical compositions for healing wounds |
| 07/22/2008 | US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/22/2008 | US7402430 Preparing synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders |
| 07/22/2008 | US7402393 Methods of screening for antagonists of APM1/GZIP |
| 07/22/2008 | US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/22/2008 | CA2320039C Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia |
| 07/22/2008 | CA2198916C Delivery of solid drug compositions |
| 07/17/2008 | WO2008086409A1 5-furopyridinone substituted indazoles |
| 07/17/2008 | WO2008086404A1 5-pyridinone substituted indazoles |
| 07/17/2008 | WO2008085921A2 Methods for reduction of adipose tissue mass |
| 07/17/2008 | WO2008085316A1 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 07/17/2008 | WO2008084962A1 THIAZOLE COMPOUND (AS PPARδ) LIGAND AND PHARMACEUTICAL, COSMETIC AND HEALTH FOOD COMPRISED THEREOF |
| 07/17/2008 | WO2008084873A1 Oxime derivative |
| 07/17/2008 | WO2008084864A1 Capsaicin receptor activator and apparatus for spraying the same |
| 07/17/2008 | WO2008084828A1 Method for producing coenzyme q10 particle |
| 07/17/2008 | WO2008084805A1 Composition for external use |
| 07/17/2008 | WO2008084303A1 Compounds having both angiotensin ii receptor antagonism and ppary activating activities |